Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP)
CUSIP: 21833P301
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 17,685,185
- Total 13F shares
- 10,952,105
- Share change
- -685,356
- Total reported value
- $129,272,235
- Put/Call ratio
- 12%
- Price per share
- $11.80
- Number of holders
- 98
- Value change
- -$16,308,014
- Number of buys
- 45
- Number of sells
- 47
Quarterly Holders Quick Answers
What is CUSIP 21833P301?
CUSIP 21833P301 identifies CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 21833P301:
Top shareholders of CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP |
13F
|
Company |
13%
|
2,375,000
|
$48,996,250 | — | 30 Sep 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
6.3%
|
1,115,000
|
$23,002,450 | — | 30 Sep 2024 | |
| ORBIMED ADVISORS LLC |
13F
13D/G
|
Company · OrbiMed Capital LLC |
5.9%
from 13D/G
|
912,552
|
$18,825,948 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
4.5%
|
802,721
|
$16,560,133 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.7%
|
645,650
|
$13,319,760 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.4%
|
600,000
|
$12,378,000 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.4%
|
595,576
|
$12,286,733 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3%
|
528,937
|
$10,911,970 | — | 30 Sep 2024 | |
| Rachael Louise Brake |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
1,400,000
|
$6,958,000 | — | 13 Feb 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.8%
|
325,668
|
$6,719,000 | — | 30 Sep 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.6%
|
284,715
|
$5,873,670 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
249,759
|
$5,153,545 | — | 30 Sep 2024 | |
| Craig Stuart Millian |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
934,645
|
$4,645,186 | — | 13 Feb 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.3%
|
221,184
|
$4,563,026 | — | 30 Sep 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
1.1%
|
195,000
|
$4,022,850 | — | 30 Sep 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.98%
|
172,630
|
$3,561,746 | — | 30 Sep 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
0.94%
|
166,794
|
$3,440,960 | — | 30 Sep 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.9%
|
160,000
|
$3,300,800 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.88%
|
154,746
|
$3,192,429 | — | 30 Sep 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.81%
|
143,356
|
$2,957,432 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.74%
|
130,170
|
$2,685,406 | — | 30 Sep 2024 | |
| Prosight Management, LP |
13F
|
Company |
0.74%
|
130,000
|
$2,681,900 | — | 30 Sep 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.72%
|
127,787
|
$2,636,246 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.58%
|
102,751
|
$2,119,753 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.53%
|
93,643
|
$1,931,855 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.52%
|
91,864
|
$1,895,155 | — | 30 Sep 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.47%
|
82,618
|
$1,704,409 | — | 30 Sep 2024 | |
| HighVista Strategies LLC |
13F
|
Company |
0.43%
|
75,292
|
$1,553,274 | — | 30 Sep 2024 | |
| Atle Fund Management AB |
13F
|
Company |
0.39%
|
69,573
|
$1,435,291 | — | 30 Sep 2024 | |
| WEXFORD CAPITAL LP |
13F
|
Company |
0.39%
|
68,556
|
$1,414,310 | — | 30 Sep 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.36%
|
64,366
|
$1,327,871 | — | 30 Sep 2024 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.28%
|
50,000
|
$1,031,500 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.28%
|
49,420
|
$1,019,535 | — | 30 Sep 2024 | |
| Artia Global Partners LP |
13F
|
Company |
0.27%
|
47,400
|
$977,862 | — | 30 Sep 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.26%
|
45,364
|
$935,859 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.24%
|
42,970
|
$886,471 | — | 30 Sep 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.24%
|
41,800
|
$874,456 | — | 30 Sep 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.22%
|
39,516
|
$815,215 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.22%
|
38,462
|
$793,470 | — | 30 Sep 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.21%
|
36,963
|
$762,547 | — | 30 Sep 2024 | |
| ClariVest Asset Management LLC |
13F
|
Company |
0.09%
|
16,021
|
$724,950 | — | 30 Sep 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.19%
|
34,039
|
$702,225 | — | 30 Sep 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.18%
|
31,295
|
$654,691 | — | 30 Sep 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.17%
|
30,810
|
$635,610 | — | 30 Sep 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.15%
|
26,894
|
$554,823 | — | 30 Sep 2024 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.15%
|
26,000
|
$536,380 | — | 30 Sep 2024 | |
| NEOS Investment Management LLC |
13F
|
Company |
0.14%
|
25,486
|
$525,776 | — | 30 Sep 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.14%
|
25,401
|
$524,023 | — | 30 Sep 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.14%
|
24,760
|
$510,799 | — | 30 Sep 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.14%
|
24,564
|
$506,000 | — | 30 Sep 2024 |
Institutional Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) as of Q4 2024
As of 31 Dec 2024,
Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,952,105 shares.
The largest 10 holders included
Cormorant Asset Management, LP, ORBIMED ADVISORS LLC, Octagon Capital Advisors LP, BlackRock, Inc., VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., MILLENNIUM MANAGEMENT LLC, Altium Capital Management LLC, Prosight Management, LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
98
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
106
Q4 2024 holders
98
Holder diff
-8
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.